UNMC Psychopharmacology Research Consortium

head

The Psychopharmacology Research Consortium at the University of Nebraska Medical Center began its work in 1984. Its purpose is to conduct research on new treatments for the relief of mental disorders.  

This research involves conditions such as depression, bipolar disorder, anxiety, attention deficit hyperactivity disorder (ADHD) and Alzheimer's disease. 

Studies include those funded by the National Institutes of Health (NIH) as well as the pharmaceutical industry. 

To learn more about the Consortium, please click on the buttons at left. 

To learn more about clinical research, click below:
Participating in Research   

For more information or to submit comments, click on our e-mail address: unmcprc@unmc.edu

 

Maintained by Delores McArthur-Miller and Daniel Jacques
Revised: January 14, 2010